Navigation Links
Statins May Slow Progression of Multiple Sclerosis, New Study Finds
Date:4/14/2010

y of Texas Southwestern Medical Center, University of Rochester, The Multiple Sclerosis Comprehensive Care Center at USC Keck School of Medicine, Yale MS Research Center, Jacobs Neurological Institute, Johns Hopkins University, and Mount Sinai School of Medicine.

The research was performed as a project of the Immune Tolerance Network, a clinical research consortium headquartered at UCSF and sponsored by the National Institute of Allergy & Infectious Diseases. Atorvastatin, placebo and additional support were provided by Pfizer. Biogen-Idec provided Avonex, an immune system regulator drug (interferon beta-1a) for study participants who displayed disease activity while on placebo or atorvastatin. Additional funding was provided by the Nancy Davis Foundation and the Maisin Foundation.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, visit www.ucsf.edu.

Follow UCSF on Twitter at http://twitter.com/ucsfnews

News release for Zamvil 2002 Nature study: http://news.ucsf.edu/releases/cholesterol-drug-could-lead-to-new-therapy-for-multiple-sclerosis/

2002 Nature paper (Youssef, et al.): http://www.nature.com/nature/journal/v420/n6911/full/nature01158.html

Immune Tolerance Network:

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Statins may slow progression of multiple sclerosis, new study finds
2. Alternative to Statins Shows Promise
3. Statins May Benefit Prostate Cancer Patients
4. Statins Show Promise Against Sickle Cell
5. More Evidence That Statins Cut Stroke Risk
6. Targeting the blood-brain barrier may delay progression of Alzheimers disease
7. Herpes Drug Might Also Slow HIV Progression
8. Self-seeding of cancer cells may play a critical role in tumor progression
9. Researchers discover gene therapy to prevent progression of emphysema
10. Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkins Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data
11. Free CME/CE Lecture and Workshop on Multiple Sclerosis: Boise, ID
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins May Slow Progression of Multiple Sclerosis, New Study Finds 
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... Healthpointe is ... its La Tijera Clinic in Los Angeles. Licensed to practice Chinese Needle Therapy since ... on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s La Mirada clinic ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Banc Intranets ... Clear System. The agreement will enable both Johnson City, Tenn.-based firms to work synergistically ... is a cloud-based safety product that caters to organizations in the financial, commercial and ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue in ... 2016. The new facility will be located at US Highway 19 North and Highlands Boulevard, ... August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Since its launch on August ... twelve offices in three counties, LA, Orange and San Bernardino. Their twenty ... Founded by Dr. Richy Agajanian, the Oncology Institute of Hope and Innovation is ...
(Date:8/27/2015)... ... August 27, 2015 , ... "I need a little help supporting and ... inventor from Camp Hill, Pa. "I developed this support handle to give me the ... AND SHOWER GRIP to provide a helping hand when stepping into or out of ...
Breaking Medicine News(10 mins):Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:Inventor and InventHelp Client Develops Bathroom Stabilization Aid (LCC-432) 2
... predict the risk of heart attack or death for patients ... ,Researchers conducted a study to determine whether blood levels ... or non-fatal heart attack in patients with acute chest pain. ... and it acts as an instigator of hardening and narrowing ...
... shows people who suffer from migraine headaches may be at ... of the brain where the tissue has died. ... 60. They grouped the patients into categories of having migraines ... A control group was also included in the study. Participants ...
... the cause of 90 percent of the world’s lung ... of cigarettes they smoke per day are exposed to ... agent. However, the reduction in the amount or concentration ... proportional to the reduction in cigarettes smoked. ,Researchers ...
... the drugs memantine and donepezil may improve // memory ... than 300 patients with moderate to severe Alzheimer’s. Participants ... began. Donepezil works by preventing the breakdown of acetylcholine, ... for memory and other thinking skills.For the study, patients ...
... Nearly 7 million patients suffering from chronic angina report ... two to three times more frequently than the general ... attacks despite current treatments, such as myocardial revascularization -- ... heart and is done largely to prevent angina -- ...
... could be significantly lowered by taking simple precautions // say ... studies in 20 centers in Europe, looking at 60 variables ... healthy infants to identify risks for SIDS. ,About 48 ... in the side or prone position. Around 16 percent of ...
Cached Medicine News:Health News:Reducing Number Of Cigarettes Not Enough 2Health News:New Medication May Decrease The Frequency Of Angina Attacks 2
(Date:8/27/2015)... , August 27, 2015 Itamar ... a private investment in public equity (PIPE) deal, in ... million in Itamar Medical.   Through this ... of Itamar Medical and will work closely with the ... According to the investment agreement, Itamar Medical will ...
(Date:8/27/2015)... Aug. 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE ... announced that it will be participating in the Goldman ... Goldman Sachs offices in London ... Company Founded in 1927 and headquartered in ... leader in musculoskeletal healthcare.  We design, manufacture and market ...
(Date:8/27/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced that it will ... ending June 30, 2015 on Friday, September 4, 2015. ... business update conference call and live webcast for investors, ...
Breaking Medicine Technology:Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3
... Oct. 14 ZyStor Therapeutics, Inc., a biotechnology company ... the treatment of Lysosomal Storage Diseases using the Company,s ... it has received clearance from the U. S. Food ... for its first drug candidate, ZC-701, an enzyme replacement ...
... Company (NYSE: LLY ) today announced the sale ... AG, one of the world,s largest chemical companies. The ... operation with a focus on producing high-quality active pharmaceutical ... In connection with the sale of the site, the ...
Cached Medicine Technology:ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 2ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 4
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... feature 20 bipolar-spaced electrodes along a ... of mapping resolution in atrial fibrillation ... 20-pole catheter enables more accurate pinpointing ... 10-pole catheter systems. The result: greater ...
Livewire TC steerable ablation catheters are designed for the RF ablation of arrhythmias. They are available in a variety of curves and configurations, including bi-directional catheters for added fl...
Medicine Products: